The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
dc.contributor.author | Kelminski, Ann | |
dc.date.accessioned | 2016-10-25T23:01:07Z | |
dc.date.available | 2016-10-25T23:01:07Z | |
dc.date.issued | 2002-09 | |
dc.identifier.issn | 0017-8594 | |
dc.identifier.pubmed | 12422387 | |
dc.identifier.uri | http://hdl.handle.net/10524/53680 | |
dc.language.iso | eng | |
dc.subject.mesh | Antineoplastic Agents, Hormonal/therapeutic use | |
dc.subject.mesh | Breast Neoplasms/prevention & control | |
dc.subject.mesh | Eligibility Determination | |
dc.subject.mesh | Female | |
dc.subject.mesh | Hawaii/epidemiology | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Patient Participation | |
dc.subject.mesh | Raloxifene Hydrochloride/therapeutic use | |
dc.subject.mesh | Randomized Controlled Trials as Topic | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Tamoxifen/therapeutic use | |
dc.title | The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer. | |
dc.type | Article | |
dc.type.dcmi | Text | |
prism.number | 9 | |
prism.pagerange | 209-10 | |
prism.publicationname | Hawaii Medical Journal | |
prism.volume | 61 |
Files
Original bundle
1 - 1 of 1